全文获取类型
收费全文 | 2510篇 |
免费 | 111篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 52篇 |
妇产科学 | 92篇 |
基础医学 | 349篇 |
口腔科学 | 36篇 |
临床医学 | 169篇 |
内科学 | 414篇 |
皮肤病学 | 28篇 |
神经病学 | 334篇 |
特种医学 | 52篇 |
外科学 | 336篇 |
综合类 | 5篇 |
预防医学 | 344篇 |
眼科学 | 27篇 |
药学 | 225篇 |
中国医学 | 2篇 |
肿瘤学 | 164篇 |
出版年
2022年 | 12篇 |
2021年 | 48篇 |
2020年 | 14篇 |
2019年 | 29篇 |
2018年 | 48篇 |
2017年 | 41篇 |
2016年 | 48篇 |
2015年 | 51篇 |
2014年 | 72篇 |
2013年 | 80篇 |
2012年 | 161篇 |
2011年 | 167篇 |
2010年 | 89篇 |
2009年 | 73篇 |
2008年 | 136篇 |
2007年 | 165篇 |
2006年 | 153篇 |
2005年 | 170篇 |
2004年 | 155篇 |
2003年 | 140篇 |
2002年 | 139篇 |
2001年 | 36篇 |
2000年 | 36篇 |
1999年 | 27篇 |
1998年 | 25篇 |
1997年 | 21篇 |
1996年 | 11篇 |
1992年 | 24篇 |
1991年 | 25篇 |
1990年 | 20篇 |
1989年 | 14篇 |
1988年 | 20篇 |
1987年 | 23篇 |
1986年 | 19篇 |
1985年 | 24篇 |
1984年 | 12篇 |
1983年 | 14篇 |
1982年 | 11篇 |
1979年 | 24篇 |
1978年 | 17篇 |
1977年 | 9篇 |
1976年 | 15篇 |
1975年 | 22篇 |
1974年 | 18篇 |
1973年 | 20篇 |
1972年 | 11篇 |
1969年 | 10篇 |
1968年 | 11篇 |
1932年 | 9篇 |
1931年 | 12篇 |
排序方式: 共有2637条查询结果,搜索用时 15 毫秒
101.
102.
Csaba M. Banki 《Psychopharmacology》1978,56(2):195-198
Cerebrospinal fluid 5-hydroxyindoleacetic acid level, and total blood serotonin content was measured in groups of manic and schizophrenic patients before and after 2, 4, 6, 10, 20, and 30 days of clozapine treatment. CSF 5-HIAA values were elevated after 2 and 4 days and returned to baseline levels after 6 days or more. Blood serotonin content, in contrast, increased gradually and remained high even after 30 days. Neither CSF 5-HIAA nor blood 5-HT correlated with age, drug dose, or clinical effectiveness, but some relationship between these and the sedative component of the clozapine action was observed. 相似文献
103.
104.
105.
106.
107.
The proportion of autologous rosette-forming, i.e. autoerythrocyte-binding, T-lymphocytes, was studied in 34 patients with untreated, operable bronchial carcinoma. The number of autorosettes in patients with bronchial carcinoma was considerably below the mean value for the normal control group. In patients with metastatic involvement of the regional lymph nodes at the time of surgery the reduction in the number of autorosettes was still more marked. On the 10th postoperative day after resection of the tumour and in case of remission five months after surgery, the number of autorosettes showed a significant rise approximating the normal value. The distribution of sheep-E-rosette-forming and of the "active-early" T-lymphocytes was also studied. On the evidence of the results, the number of autorosette-forming lymphocytes lends itself to a follow-up of bronchial carcinoma by early demonstration of remissions or recurrences. 相似文献
108.
Survivin splice variants regulate the balance between proliferation and cell death 总被引:25,自引:0,他引:25
Caldas H Jiang Y Holloway MP Fangusaro J Mahotka C Conway EM Altura RA 《Oncogene》2005,24(12):1994-2007
Survivin is an inhibitor of apoptosis protein that also plays critical roles in regulating the cell cycle and mitosis. Its prominent expression in essentially all human malignancies, and low or absent expression in most normal tissues, suggests that it would be an ideal target for cancer-directed therapy. Impeding development of safe and effective survivin antagonists for clinical use is a lack of understanding of the molecular mechanisms by which survivin differentially affects apoptosis and cell division, in normal and malignant cells. We show that the diverse functional roles of survivin can be explained, in part, by its heterodimerization with survivin splice variants in tumor cells. Survivin and survivin-DeltaEx3 interact within the mitochondria where they may inhibit mitochondrial-dependent apoptosis. If the expression of all survivin forms is eliminated by siRNA transfections, cells undergo both apoptosis and defective cell division. Overall, we provide new insights suggesting that targeting specific survivin isoforms, rather than survivin alone, may selectively and effectively destroy tumor cells. These findings are likely to have a significant impact in the design of biologic agents for clinical therapy. 相似文献
109.
Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex 总被引:1,自引:0,他引:1
Chen B Gajdos C Dardes R Kidwai N Johnston SR Dowsett M Jordan VC 《International journal of oncology》2005,27(2):327-335
The ratio of estrogen receptor beta (ERbeta) to ERalpha can alter the estrogen-like properties of tamoxifen. Transient transfection of ERbeta cDNA into cells can decrease the estrogen-like properties of the ERalpha:tamoxifen complex, whereas an increase in the amount of ERbeta is associated with tamoxifen-resistant breast cancer. We have addressed each of these hypotheses by examining well characterized laboratory models. We determined whether changes in endogenous ERbeta are responsible for the estrogen-like or antiestrogenic properties of tamoxifen or raloxifene in MDA-MB-231 cells transfected with cDNAs for ERalpha or mutants D351G, D351Y. We found that the amount of ERbeta mRNA in separate, stable transfectants of mutant ERalpha cDNA was always < 2% of ERalpha. Since at least a 50:50 mixture of ERalpha:ERbeta is needed to silence the tamoxifen:ERalpha complex, we conclude that insufficient ERbeta mRNA is available for selective ER modulation in stable transfectants of D351G and D351Y ERalpha. Similarly, to test the hypothesis that ERbeta is up-regulated and plays an important role during the development of tamoxifen-stimulated tumor growth, we quantitatively analyzed ERbeta and ERalpha mRNA in tamoxifen-na?ve (MCF-7:E2, ECC1:E2) and tamoxifen-stimulated tumors (MCF-7:TAM, EnCa 101:TAM). We found that ERbeta mRNA levels were not significantly elevated in tamoxifen-stimulated tumors and the ERalpha mRNA remained over 99% out of all ER species for all the tumors tested. The same results were also obtained when mRNA levels of ERbeta and ERalpha in a series of tamoxifen-na?ve and tamoxifen-resistant breast cancer was analyzed. We conclude that endogenous ERbeta may not play a dominant role in the modulation of the tamoxifen ERalpha complex, or in the development of tamoxifen-stimulated resistant tumor growth. 相似文献
110.